UNSPSC 85444503: The diagnosis of chloramphenicol group

In this classification, this covers the group of activities that yields a diagnosis of chloramphenicol group. Chloramphenicol group is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y40.2.

UNSPSC 85444503 The diagnosis of chloramphenicol group is a Commodity code that presents a significant mismatch between its nominal scope and actual state and local procurement activity. The code's name references a specific pharmaceutical diagnostic category, yet the recent opportunities posted under this code encompass diagnostic imaging systems, special education contracted services, and temporary health professional staffing—none of which involve chloramphenicol diagnosis or pharmaceutical testing. State and local procurement offices appear to have tagged these opportunities with this code in error or as a fallback classification, suggesting the code itself does not reliably reflect what is actually being bought in the market. The recent opportunities show health systems and school districts sourcing broad clinical services and infrastructure rather than a narrow pharmaceutical diagnostic product line.

Recent activity includes San Mateo Medical Center's RFP for enterprise-grade Diagnostic Imaging PACS implementation (due October 21, 2026), Birdville Independent School District's RFQ for special education contracted services spanning 23 line items including therapies and evaluations (due October 21, 2026), and Santa Clara County Health System's qualification-based multiple-award solicitation for temporary health professional staffing across 13 ancillary clinical categories including audiology, radiology, and therapy services (due October 7, 2026). Issuing bodies span county health systems, public hospitals, and independent school districts primarily in California and Texas. The code shows little relevant recent activity aligned to its stated pharmaceutical diagnostic scope, and vendors pursuing opportunities tagged with this code should validate actual service requirements directly with the issuing body rather than rely on the code name to guide proposal development.